Koninklijke Philips NV vs Vanguard Value Index Fund ETF — how do they compare? Koninklijke Philips NV trades at $26.53 (market cap $25.89B), while Vanguard Value Index Fund ETF trades at $219.58. The key difference: Koninklijke Philips NV pays a 3.81% dividend while Vanguard Value Index Fund ETF pays none, and Vanguard Value Index Fund ETF is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| PHG | VTV | |
|---|---|---|
Market Cap | $25.89B | — |
Sector | Health | — |
52-Week High | $32.91 | $220.51 |
52-Week Low | $25.02 | $175.51 |
Enterprise Value | $32.18B | — |
Dividend Yield | 3.81% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
VTV trades at $218.63, up 0.33% with a bullish technical outlook from moving averages. The ETF focuses on large-cap value stocks, offering diversification with low tech exposure and a 0.03% expense ratio. Recent news highlights its role as a stability play amid AI volatility, with a 16% YTD gain and a 27% one-year advance as of July 2026.
Outlook remains positive due to investor rotation into value stocks and Fed policy sensitivity. Risks include inflation-driven rate hikes and concentrated sector bets. Analyst sentiment favors VTV for defensive positioning, but macroeconomic shifts could challenge momentum.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →